Infectious Disease Control

US State Turns on COVID-19 Vaccine Appointment Scheduling Hotline in Less Than a Day with Bright Pattern

COVID-19 vaccine appointment hotline deployed in record time – 23 hours – by Atento and Bright Pattern with an agreement for 1500 agents SOUTH SAN FRANCISCO, Calif., April 1, 2021 /PRNewswire/ -- Bright Pattern, a leading provider of AI-poweredcloud contact center software, has been deployed to ...

2021-04-01 23:03 3621

CKGSB Economist Develops Dynamic Model for Reopening Strategies amid COVID-19

BEIJING, April 1, 2021 /PRNewswire/ -- With the COVID-19 vaccine being rolled out, many local and national governments are assessing how to safely reopen their economies while curtailing the number of positive cases. Professor of Economics,Zhong Ling, at the Cheung Kong Graduate School of Busines...

2021-04-01 13:36 1579

Ortho Announces Plans to Accelerate COVID-19 Antigen and Antibody Test Development Through New Contract with BARDA and the Department of Defense

RARITAN, N.J., April 1, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play IVD companies, today announced that through its continued partnership with the Biomedical Advanced Research and Development Authority (BARDA) and the U.S. Department of Def...

2021-04-01 08:03 2001

Future Health: Innovative Health Around the World

LONDON, March 31, 2021 /PRNewswire/ -- It started with the UK but the renowned organisers of Future Health Innovation have recently announced the launch of a full series of digital events - the Health Week Series. Concentrating on key markets around the world, there will be a Summer and Autumn ev...

2021-03-31 18:36 2251

binx health Receives FDA CLIA Waiver for Chlamydia and Gonorrhea Test, Expanding Critical Access to Single-Visit Diagnoses

First ever 30-minute, CLIA-waived, molecular PCR Test for CT/NG now available for OBGYN, physician offices and retail settings holding certificates of waiver BOSTON, March 31, 2021 /PRNewswire/ -- binx health, a population health technology company that provides convenient healthcare solutions, a...

2021-03-31 06:11 2259

HI-NANO: Hisense's new technology inactivates COVID-19 with a rate up to 93.54%

PARIS, March 30, 2021 /PRNewswire/ -- Hisense's HI-NANO technology is certified effective on inducing the novel coronavirus (SARS-CoV-2) with an inhibition rate of 93.54% by Texcell, a global contract research organization. The test was performed at Texcell's laboratory inParis in February 2021. ...

2021-03-30 16:25 8613

Discussing Expansion of Travel Corridor Arrangement, Minister of Tourism Holds a Coordination Meeting

BALI, Indonesia, March 29, 2021 /PRNewswire/ -- Minister of Tourism and Creative Economy, Sandiaga Salahuddin Uno, organizes a ministerial coordination meeting regarding the expansion of the travel corridor arrangement for the tourism and creative economy sector, which allows return tourist visit...

2021-03-29 17:06 5703

Johnson & Johnson Announces Advance Purchase Agreement with the African Vaccine Acquisition Trust for the Company's COVID-19 Vaccine Candidate

NEW BRUNSWICK, N.J., March 29, 2021 /PRNewswire/ -- Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE: JNJ) (the Company), has entered into an agreement with the African Vaccine Acquisition Task Team (AVATT) to make available up to 220 million dos...

2021-03-29 16:07 5907

China Eastern Flies Vaccines to Dominican Republic

SHANGHAI, March 25, 2021 /PRNewswire/ -- A new batch of vaccines developed by Chinese pharmaceutical companies Sinopharm and Sinovac was delivered onMarch 18 by China Eastern Airlines fromBeijing to the Dominican Republic, according to theShanghai-based airline.

2021-03-25 19:22 2049

RDIF: Sputnik V approved in Vietnam

MOSCOW, March 23, 2021 /PRNewswire/ -- The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces the approval of the Russian Sputnik V vaccine against coronavirus by the Ministry of Health of the Socialist Republic ofVietnam. Thus Sputnik V is now approved for use in 56...

2021-03-23 20:45 3038

CanSinoBIO Announces Approval for its Single-Dose COVID-19 Vaccine Convidecia™ in Hungary

* Marks vaccine's first approval by an European Union member state, following Mexico, Pakistan and China * Continues to boost production capacity to meet increasing demand * Safe, stable storage and transportation between 2°C and 8°C, accessible by under-developed regions * 95.47% effectiv...

2021-03-23 00:43 4354

PathogenDx Applauded by Frost & Sullivan for Its Ultra-rapid COVID-19 Testing Platform, DetectX-Rv Test

PathogenDx's disruptive nucleic acid-based test uses a multiplex microarray to rapidly identify, detect, and quantify multiple pathogens and viral strains SANTA CLARA, Calif., March 22, 2021 /PRNewswire/ -- Based on its recent analysis of the global molecular testing market,Frost & Sullivan recog...

2021-03-22 22:00 1963

SDI Adds Acteev Protect™ Masks to Portfolio of PPE As-a-Service(SM)

The digital supply chain solutions provider adds the masks with antimicrobial protection to its worry-free materials management program HOUSTON, March 18, 2021 /PRNewswire/ -- SDI, a leader in digital supply chain services and solutions, has added a new line of antimicrobial protective gear to i...

2021-03-18 21:00 5679

FDI - Dental disaster: One year after first lockdowns dentists around the world confront the consequences of the COVID-19 pandemic on people's oral health: higher incidence of tooth decay and more advanced gum disease

GENEVA, March 18, 2021 /PRNewswire/ -- Ahead of World Oral Health Day (WOHD) on Saturday 20 March and one year into the pandemic, FDI councillors and members say they are seeing first-hand the catastrophic aftermath of the virus on the health of people's teeth...

2021-03-18 15:00 3959

Merck Accelerates European Expansion Plans for Single-use Products Critical to Manufacturing Vaccines and Lifesaving Therapies

DARMSTADT, Germany, March 17, 2021 /PRNewswire/ -- Merck, a leading science and technology company, will add a single-use assembly production unit at its Life Science Center in Molsheim,France. With the € 25 million investment, the company is accelerating its European expansion plans for this key...

2021-03-17 23:40 3652

GenScript and G42 Healthcare announce collaboration to provide innovative solutions to fight against COVID-19

SINGAPORE, March 17, 2021 /PRNewswire/ -- GenScript Biotech Singapore, a subsidiary of GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a world leading biotechnology company, and G42 Healthcare, a leading healthcare technology company, based in the UAE, today announced they have ...

2021-03-17 17:23 4278

The Public Health Agency of Canada and the University of Manitoba recruiting a scientific leader to head Canada's National Microbiology Laboratory

WINNIPEG, MB, March 16, 2021 /PRNewswire/ -- The Public Health Agency of Canada and theUniversity of Manitoba are collaborating in the recruitment of a scientific leader in infectious disease laboratory science to leadCanada's National Microbiology Laboratory (NML). This individual will hold a fa...

2021-03-16 03:19 1410

Novavax Confirms High Levels of Efficacy Against Original and Variant COVID-19 Strains in United Kingdom and South Africa Trials

- 100% protection against severe disease - Final analysis in U.K. trial confirms 96% efficacy against original strain of COVID-19 - Efficacy against variants confirmed in U.K. and South Africa GAITHERSBURG, Md., March 12, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnolog...

2021-03-12 05:04 4548

Largest-ever installation of LightAir Health+

STOCKHOLM, March 11, 2021 /PRNewswire/ -- LightAir has received an order for a large installation of air purifiers and virus inhibitors within its Professional Solutions segment. The American International School ofBucharest has ordered an air purification capacity of approximately100,000 m3/h, w...

2021-03-11 20:50 2345

Zymo Research Receives 510(k) Clearance for its Collection/Transport Device for COVID-19

IRVINE, Calif., March 11, 2021 /PRNewswire/ -- Zymo Research announced today the U.S. Food and Drug Administration (FDA) has cleared itsDNA/RNA Shield™ Collection Tube as a Class II medical device. The FDA's 510(k) clearance allows the product to be used as an In-vitro Diagnostic (IVD) device for...

2021-03-11 14:37 3097
1 ... 36373839404142 ... 44